- CEO
- Manfred Stanek
- Full Time Employees
- 3,894
- Sector
- Industrials
- Industry
- Industrial - Machinery
- Address
- Am Belvedere 10 Vienna Austria 1100
- IPO Date
- Oct 24, 2016
- Business
- Semperit AG Holding is an Austria-based international group that develops, produces and markets highly specialised polymer and elastomer products for industrial applications. The company operates through key segments including Semperflex, which manufactures hydraulic and industrial hoses reinforced with fabric or wiring; Sempertrans, which produces transport and conveyor belts such as steel cord belts and textile belts; Semperform, which focuses on moulded and extruded products including escalator handrails, cable car rings and railway superstructure products; and Semperseal, which supplies sealing profiles and gaskets for construction elements, windows, doors, facades and other industrial uses. Its product portfolio also encompasses construction profiles and specialised components for mission-critical systems across sectors like mining, infrastructure, manufacturing and transportation, with production supported by 15 manufacturing facilities and sales offices in Europe, Asia, the Americas and Australia.
Founded in 1824 by Johann Nepomuk Reithoffer with the establishment of Europe's first rubber products factory in Wimpassing, Lower Austria, Semperit AG Holding maintains its headquarters at Modecenterstr. 22 in Vienna, Austria, and employs over 4,000 people worldwide, including a global R&D centre in Wimpassing.
In recent strategic developments, Semperit completed the acquisition of RICO Group in August 2023, a leading supplier of customised elastomer and plastics applications with expertise in liquid silicone injection moulding and high-end mould production, enhancing its technology leadership in silicone components for healthcare, industrial household applications and North American markets while generating approximately EUR 90 million in revenue for RICO in fiscal 2022. The company sold its medical business, Sempermed—previously focused on examination, protective and surgical gloves—to HARPS Global PTE in 2023, enabling a sharpened focus on its industrial core operations. Further advancements include the sale of its Surgical Operations division effective 30 June 2024 and a co-use agreement with HARPS concluded on 21 March 2024, alongside ongoing earnings improvements in 2025 with Q3 EBITDA rising to EUR 21.3 million amid a challenging market.